ID Board Review/Fungi

Fungi account for 5% of the ABIM ID Certification Exam. Based off the ABIM blueprint, therapies, specific diagnostic testing and syndromes may be emphasized more than Bacterial or Viral Diseases.

Yeasts

• Candida spp
• Cryptococcus
• Other yeasts
  • Trichosporon
  • Saccharomyces

Endemic mycoses

• Histoplasma
• Blastomyces dermatitidis
• Coccidioides spp
  • Coccidioides immitis
  • Coccidioides posadasii
• Sporothrix schenckii
• Paracoccidioides brasiliensis
• Talaromyces marneffei (Previously Penicillium marneffei)

Molds

• Hyaline Molds
  • Aspergillus spp
• Agents of Zygomycosis (mucormycosis)
• Dematiaceous Molds
  • Bipolaris
  • Exophiala
  • Others:Scedosporium apiospermum/Pseudallescheria Boydii

Superficial and subcutaneous mycoses

• Mycetoma
• Chromoblastomycosis
• Malassezia
• Dermatophytes

Therapy

• Pharmacokinetics
• Drug interactions
• Spectrum
• Toxicity
• Prophylaxis
• Susceptibility testing
• Drug resistance

Diagnostic testing

• Histopathology
• Culture
• Nonculture methods

Syndromes

• Mucosal
• Skin
• Pulmonary
• Central nervous system and eyes
• Cardiac
• Disseminated